Axonics (NASDAQ:AXNX) Given New $63.00 Price Target at Needham & Company LLC

Axonics (NASDAQ:AXNX – Free Report) had its target price cut by Needham & Company LLC from $76.00 to $63.00 in a research report sent to investors on Tuesday morning, Benzinga reports. They currently have a buy rating on the stock. A number of other research analysts also recently commented on the stock. Robert W. Baird […]

Related Keywords

Canada ,United States ,America ,Robertw Baird ,Alfredj Ford Jr ,Dannyl Dearen ,Leerink Partnrs ,Royal Bank ,Securities Exchange Commission ,Norges Bank ,Mackenzie Financial Corp ,Axonics Company Profile ,Vanguard Group Inc ,Needham Company ,America Corp ,Axonics Inc ,Free Report ,Get Free Report ,Exchange Commission ,Financial Corp ,Axonics Daily ,Axonics ,Nasdaq Axnx ,Axnx ,Medical ,Lower Price Target ,Needham Amp Company Llc ,